Cargando…

Combined Effect of Smoking and Fatty Liver Disease on the Progression of Type 2 Diabetes: Insights from a Population-Based Cohort Study

OBJECTIVES: Fatty liver disease (FLD) is strongly linked to the occurrence of type 2 diabetes mellitus (T2DM). Insulin resistance (IR) is linked to smoking. Our study's purpose was to see how smoking and fatty liver accompanied affected the development of T2DM in the past. MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tingting, Zhang, Donghe, Zeng, Jing, Yang, Yan, Fang, Yi, Wang, Xuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288327/ https://www.ncbi.nlm.nih.gov/pubmed/35855836 http://dx.doi.org/10.1155/2022/1776875

Ejemplares similares

Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
por: Du, Tingting, et al.
Publicado: (2015)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia
por: Zhang, Shujun, et al.
Publicado: (2017)

Active Smoking, Passive Smoking, and Risk of Nonalcoholic Fatty Liver Disease (NAFLD): A Population-Based Study in China
por: Liu, Yu, et al.
Publicado: (2013)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Impact of non-alcoholic fatty liver disease and smoking on colorectal polyps
por: Chen, Qin-Fen, et al.
Publicado: (2017)

Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?
por: Nguyen, Xuan-vinh Kevin, et al.
Publicado: (2022)

Editorial: new insights into the relationship between the intestine and non‐alcoholic fatty liver—is “fatty gut” involved in disease progression?
por: Valenti, L., et al.
Publicado: (2017)

ER Stress and Autophagy Dysfunction Contribute to Fatty Liver in Diabetic Mice
por: Zhang, Quan, et al.
Publicado: (2015)

Cigarette Smoking Increased Risk of Overall Mortality in Patients With Non-alcoholic Fatty Liver Disease: A Nationwide Population-Based Cohort Study
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2020)

Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
por: Zeng, Pei, et al.
Publicado: (2023)

Change in Liver Fibrosis Associates with Progress of Diabetic Nephropathy in Patients with Nonalcoholic Fatty Liver Disease
por: Terasaka, Yoshiko, et al.
Publicado: (2023)

HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population
por: Zeng, Pei, et al.
Publicado: (2023)

Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention
por: Orabi, Danny, et al.
Publicado: (2021)

Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study
por: Li, Yaru, et al.
Publicado: (2017)

Fatty liver and mortality: a cohort population study in South Italy
por: Caruso, Maria Gabriella, et al.
Publicado: (2019)

The association between fatty liver index and onset of diabetes: secondary analysis of a population-based cohort study
por: Zhu, Yanqiong, et al.
Publicado: (2023)

Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects
por: Zhang, Shujun, et al.
Publicado: (2017)

Helicobacter pylori infection increases the risk of nonalcoholic fatty liver disease in diabetic population
por: Chen, Yi, et al.
Publicado: (2023)

Combining serum uric acid and fatty liver index to improve prediction quality of nonalcoholic fatty liver disease
por: Ding, Yajie, et al.
Publicado: (2023)

Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
por: Arrese, Marco, et al.
Publicado: (2021)

Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study
por: Okamoto, Masashi, et al.
Publicado: (2018)

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
por: Ou, Hongjie, et al.
Publicado: (2019)

Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population
por: Zou, Jiawang, et al.
Publicado: (2022)

Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease
por: Zhang, Ni, et al.
Publicado: (2023)

Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population
por: SILAGHI, CRISTINA ALINA, et al.
Publicado: (2016)

Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns
por: Zeng, Fanhong, et al.
Publicado: (2021)

Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease
por: Li, Bai, et al.
Publicado: (2022)

Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis
por: Zeng, Chuanfei, et al.
Publicado: (2022)

Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
por: Endo, Hitoshi, et al.
Publicado: (2013)

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Prediction of Metabolic Syndrome by Non-Alcoholic Fatty Liver Disease in Northern Urban Han Chinese Population: A Prospective Cohort Study
por: Zhang, Tao, et al.
Publicado: (2014)

Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis
por: Liu, Lili, et al.
Publicado: (2023)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Research Progress of Pyroptosis in Fatty Liver Disease
por: Li, Rongxuan, et al.
Publicado: (2023)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

β-cryptoxanthin and fatty liver disease: new insights
por: Clugston, Robin D.
Publicado: (2023)

The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population
por: Rabiee, Behnam, et al.
Publicado: (2017)

Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus
por: Xu, Jingyuan, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study
por: Han, Byoungduck, et al.
Publicado: (2022)

Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats
por: Zou, Wenlan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9s7o3rdhhs5clucpqsparfsbdq